Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
J Neurosurg Pediatr ; 28(3): 278-286, 2021 Jun 25.
Article in English | MEDLINE | ID: mdl-34171833

ABSTRACT

OBJECTIVE: Rapid-sequence MRI (RSMRI) of the brain is a limited-sequence MRI protocol that eliminates ionizing radiation exposure and reduces imaging time. This systematic review sought to examine studies of clinical RSMRI use for pediatric traumatic brain injury (TBI) and to evaluate various RSMRI protocols used, including their reported accuracy as well as clinical and systems-based limitations to implementation. METHODS: PubMed, EMBASE, and Web of Science databases were searched, and clinical articles reporting the use of a limited brain MRI protocol in the setting of pediatric head trauma were identified. RESULTS: Of the 1639 articles initially identified and reviewed, 13 studies were included. An additional article that was in press at the time was provided by its authors. The average RSMRI study completion time was variable, spanning from 1 minute to 16 minutes. RSMRI with "blood-sensitive" sequences was more sensitive for detection of hemorrhage compared with head CT (HCT), but less sensitive for detection of skull fractures. Compared with standard MRI, RSMRI had decreased sensitivity for all evidence of trauma. CONCLUSIONS: Protocols and uses of RSMRI for pediatric TBI were variable among the included studies. While traumatic pathology missed by RSMRI, such as small hemorrhages and linear, nondisplaced skull fractures, was frequently described as clinically insignificant, in some cases these findings may be prognostically and/or forensically significant. Institutions should integrate RSMRI into pediatric TBI management judiciously, relying on clinical context and institutional capabilities.

2.
J Clin Neurosci ; 87: 112-115, 2021 May.
Article in English | MEDLINE | ID: mdl-33863517

ABSTRACT

The study objective was to evaluate a single institution experience with adult stereotactic intracranial biopsies and review any projected cost savings as a result of bypassing intensive care unit (ICU) admission and limited routine head computed tomography (CT). The authors retrospectively reviewed all stereotactic intracranial biopsies performed at a single institution between February 2012 and March 2019. Primary data collection included ICU length of stay (LOS), hospital LOS, ICU interventions, need for reoperation, and CT use. Secondarily, location of lesion, postoperative hematoma, neurological deficit, pathology, and preoperative coagulopathy data were collected. There were 97 biopsy cases (63% male). Average age, ICU LOS, and total hospital stay were 58.9 years (range; 21-92 years), 2.3 days (range; 0-40 days), and 8.8 days (range 1-115 days), respectively. Seventy-five (75 of 97) patients received a postoperative head CT. No patients required medical or surgical intervention for complications related to biopsy. Eight patients required transfer from the ward to the ICU (none directly related to biopsy). Nine patients transferred directly to the ward postoperatively (none required transfer to ICU). Of the patients who did not receive CT or went directly to the ward, none had extended LOS or required transfer to ICU for neurosurgical concerns. Eliminating routine head CT and ICU admission translates to approximately $584,971 in direct cost savings in 89 cases without a postoperative ICU requirement. These practice changes would save patients' significant hospitalization costs, decrease healthcare expenditures, and allow for more appropriate hospital resource use.


Subject(s)
Brain Neoplasms/diagnostic imaging , Cost Savings/methods , Health Care Costs , Neuronavigation/methods , Patient Safety , Tomography, X-Ray Computed/methods , Adult , Aged , Aged, 80 and over , Biopsy/adverse effects , Biopsy/economics , Biopsy/methods , Brain Neoplasms/economics , Brain Neoplasms/pathology , Cost Savings/economics , Female , Humans , Intensive Care Units/economics , Length of Stay/economics , Male , Middle Aged , Neuronavigation/adverse effects , Neuronavigation/economics , Patient Safety/economics , Retrospective Studies , Tomography, X-Ray Computed/economics , Young Adult
3.
Semin Thorac Cardiovasc Surg ; 33(3): 825-829, 2021.
Article in English | MEDLINE | ID: mdl-33450408

ABSTRACT

The transition of the USMLE to a pass fail system provides a unique opportunity to re-evaluate the residency selection process.


Subject(s)
Internship and Residency , Educational Measurement , Humans , United States
5.
Neurosurg Focus ; 35(4): E2, 2013 Oct.
Article in English | MEDLINE | ID: mdl-24079781

ABSTRACT

OBJECT: The goal of this study was to review the current literature on orthotic (helmet) therapy use in the treatment of deformational plagiocephaly. METHODS: PubMed was used to search English articles using the medical subject headings "deformational plagiocephaly" and "orthosis," and "deformational plagiocephaly" and "helmet." RESULTS: Forty-two articles were found. There were no Class I studies, 7 Class II studies, 1 Class III study, and 13 Class IV studies. Cranial orthoses have been shown to be effective in treating deformational plagiocephaly. It continues to be debated as to whether the statistical significance of treatment with cranial orthoses compared with conservative therapies is clinically significant. Children older than 12 months of age with deformational plagiocephaly may still benefit from orthotic therapy. The long-term effects of orthotic therapy are controversial. CONCLUSIONS: There is a lack of Class I literature evidence supporting the use of helmet therapy in deformational plagiocephaly. There are controversies surrounding the use of orthotic therapy such as appropriate use, cost, use in older children, and long-term outcomes. Clinical indications for orthotic therapy need to be better defined with further research studies.


Subject(s)
Head Protective Devices , Plagiocephaly/therapy , Age Factors , Child , Child, Preschool , Female , Head Protective Devices/adverse effects , Humans , Infant , Infant, Newborn , Male , Orthotic Devices , Plagiocephaly/pathology , Plagiocephaly, Nonsynostotic/therapy , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...